Global qPCR and dPCR Instrumentation Market Report 2021: Market to Reach $9.2 Billion by 2026 – Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market – ResearchAndMarkets.com – Press Release

NewsReport June 29, 2021

0 1 3 minutes read

[ad_1]

The “qPCR and dPCR Instrumentation – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for qPCR and dPCR Instrumentation estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2026, growing at a CAGR of 9.8% over the analysis period. qPCR, one of the segments analyzed in the report, is projected to grow at a 9.3% CAGR to reach US$8.4 Billion by the end of the analysis period.

After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the dPCR segment is readjusted to a revised 13% CAGR for the next 7-year period. This segment currently accounts for a 12.5% share of the global qPCR and dPCR Instrumentation market.

Real-Time PCR also referred to as Quantitative PCR (qPCR) analysis, is a modification of the traditional PCR technique. In traditional Polymerase Chain Reaction (PCR), the amplified DNA product or amplicon is detected in an end-point analysis by visualization of the DNA product on an agarose gel subsequent to completion of the reaction, which comprises a specified number of amplification cycles.

In real-time PCR, however, the accumulation of amplification product is evaluated simultaneously with the progress of the reaction. Product quantification is carried out in real time, after every cycle. Digital PCR (dPCR) is an improvement of traditional PCR methods and is utilized to directly quantify as well as clonally amplify nucleic acids such as DNA, RNA, cDNA or methylated DNA.

However, digital PCR is at an early stage. The main difference between conventional PCR and dPCR lies in the method used to measure amounts of nucleic acids. Sensitivity of dPCR is high in comparison to qPCR, hence, the technology is particularly used in applications wherein there is a low amount of target sequence. For instance, mutation genes that are found on a very low scale in rare diseases, and HIV DNA that are present in 1,000-10,000 in number within the cell of a patient can be easily detected through the technology.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
Impact of COVID-19 on Clinical Diagnostics Sector
Emergence of PCR as a Preferred COVID-19 Detection Method
Performance Analysis of COVID-19 Tests
Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market
Select Approved Covid-19 Molecular Assay Tests
Recent PCR Based Tests
Digital PCR Sparks Increasing Interest
High-Speed NanoPCR Technology Developed for Point-of-Care Diagnosis of COVID-19
CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19 Diagnostic Market
Demand for PCR Testing to Remain Buoyant in 2021
Real-Time PCR and Digital PCR: Scope and Definition
Real-Time PCR or Quantitative PCR (qPCR)
qPCR Instrumentation
Disadvantages
Advantages of qPCR
End-Use Applications of qPCR
Digital PCR (dPCR)
Working Principle
Applications of dPCR
Advantages of dPCR
qPCR Remains the Mainstay Technology
Digital PCR to Experience Strong Growth
High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR
Developing Countries Drive Growth Opportunities
Competition
Competitive Factors
Accelerated Commercialization of Products
Manufacturers Step-Up Online Exposure
Targeted Expansion of Distribution Reach and Global Footprint
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

Agilent Technologies, Inc.
Becton, Dickinson and Company
BioFire Diagnostics, Inc.
Bio-Rad Laboratories, Inc.
Cepheid
Eppendorf AG
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
Promega Corporation
QIAGEN N.V.
RainDance Technologies, Inc.
Takara Bio, Inc.
Thermo Fischer Scientific Inc.

3. MARKET TRENDS & DRIVERS

Striking the Right Balance between qPCR and dPCR in Research Laboratories
qPCR: A Suitable Tool for Gene Expression and Validation
Digital PCR Takes Quantification of Nucleic Acids to the Next Level
dPCR: A Valuable Tool in Virology Research
Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR
dPCR for Analyzing Hematologic Malignancies
dPCR for Liquid Biopsies
Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies
Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
Rise in Infectious Diseases Drives Opportunities for Biochips
Innovations in Instrumentation Expand Functionality and Drive Adoption
Advancements in Probe Technology Enhance qPCR Sensitivity
qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment
Lab on Chip/Microfluidic Real-time-PCR
Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years
ddPCR: The More Advanced Digital Approach to dPCR
ddPCR Gains Traction in Cancer Diagnosis
Monitoring Disease Progression in HIV Studies
Analysis of Genetically Modified Organisms in Edible Products
RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples
Technology Advancements Aid in Overcoming Barriers
Alternate Technologies Pose Threat to Growth of PCR Market
Next-Generation Sequencing to Emerge as Novel Technique in Fight with COVID-19
Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests
PCR in Forensic and Paternity Testing